ML339 is a potent and selective CXCR6 antagonist with an IC50 of 140 nM. It demonstrates high selectivity, showing no activity against CXCR5 or CXCR4. This inhibitor is a valuable research tool for studying CXCR6-mediated functions in inflammation and cancer in both cellular and animal models.